Cystic Fibrosis Trust & Cystic Fibrosis Foundation-funded research programme exploring the use of lung MRI in cystic fibrosisRead more about our work here & listen to our appearance on the CForYourself podcast via this link (Series 2, Episode 5).
Latest news:
Contact us:
23/10/2025
What is the study about?MAGNIFY is a research study funded by the CF trust that aims to look at the lung health of a variety of people with Cystic Fibrosis over time. To do this, we would like to take detailed pictures of the lungs using a type of clinical scan called Magnetic Resonance Imaging (MRI), which is able to detect small changes in the lungs when a special gas called Xenon is inhaled. It has been shown that these pictures are much better than the current breathing tests used in clinic to measure changes in the lungs.We would like to use these pictures to find out how well the new medicines in Cystic Fibrosis treat lung disease and ensure that when treatment becomes available for those who cannot take the new medicines, we are able to accurately measure any changes in the lungs following treatment. As well as the MRI scan, participants will be asked to perform a selection of breathing tests to access whether some breathing tests are able to better monitor lung disease in CF than what is currently used in clinic.
Here is an example of the pictures we can take of the lungs!
We can take these pictures frequently as an MRI scan does not involve any ionising radiation, so it is completely safe to perform lots of times. It can also tell us whereabouts in the lung the problem is, helping to guide doctors and treatment. We have been performing these types of MRI scans in Sheffield for over 10 years, scanning both children and adults with many different lung conditions.Can I get involved?If you have Cystic Fibrosis and are over the age of 5 years you may be eligible to take part.We are looking for:• Adults and children (+5 years) who are not taking modulators (such as Kaftrio) or have not been able to tolerate them.Where will testing take place?The research study will take place at The University of Sheffield, Royal Hallamshire Hospital, Sheffield, UK.
Here is a picture of our MRI scanner in Sheffield
What will I be asked to do?You will be asked to attend 3 study visits over a period of 3 years, approximately 6-12 months apart depending on your study group. Visits will last approximately 3 hours, during which you will be required to have an MRI scan that last approximately 45 minutes and perform and selection of breathing tests. The breathing tests included in the study are multiple breath washout, oscillometry, spirometry and body plethysmography. All the breathing tests are easy to perform and mostly involve normal relaxed breathing. Reasonable travel expenses will be reimbursed for these visits, and a £20 gift voucher will be provided as a thank you for your time and effort.For more information about the MRI scan and what each of these breathing tests entail please contact our research team for an age specific information sheet.
Next stepsIf you require further information or wish to get involved in the study, then please get in touch with our research team via email or telephone.
Telephone: 0114 2159595
Email: [email protected]
23/10/2025
The MAGNIFY SRC, funded by the CF, Trust is focused on exploring the use of lung magnetic resonance imaging (MRI) in CF. Lung MRI has the potential to help in both the monitoring and management of CF, as well as in testing new inhaled therapies.The SRC includes a number of separate PhD projects, including this one, focused on developing materials to help healthcare professionals, people with CF and their carers better understand and discuss the results of lung MRI scans. Would you please consider joining a research interview to review the toolkit we have developed?The details are available here – I would be grateful if you would consider taking part and sharing the opportunity with others who may be interested in doing the same.If you have any queries about the research then please do not hesitate to contact Daniel Beever, PhD student at [email protected].You can also find out more information about the MAGNIFY SRC here: https://www.cysticfibrosis.org.uk/the-work-we-do/research/cf-research-topics/understanding-and-treating-symptoms/magnify-src-pulmonary-magnetic-resonance.

Welcome to ‘In Focus’, the blog for the MAGNIFY Strategic Research Centre. MAGNIFY is a research programme funded by the Cystic Fibrosis Trust and Cystic Fibrosis Foundation.All of our blogs are available below:Blog 1: November 2025

From left to right: Jonathan, Demi, Yves & Dan
[DATE]
Welcome!In this first blog, we explain more about MAGNIFY, our students & presenting our work at the recent UK CF Conference!What is MAGNIFY?MAGNIFY is a research programme looking at how we can develop the use of lung magnetic resonance imaging (MRI) in cystic fibrosis (CF). MRI is able to provide us with detailed information about the lungs which we think could be really useful in the management and monitoring of CF. You can read more about this in an article written by the CF Trust here.We call it a ‘programme’ as it is made up of 4 separate projects, each led by a different PhD student and supervised by other members of our team. Our first student started in October 2023 and our most recent in March 2025. Our team work at the University of Sheffield, University of Nottingham and University of Manchester.What is MRI?Magnetic resonance imaging or MRI, is a type of medical scan that can visualise the internal structures of our bodies. The experience is similar to having an X-ray or CT scan, though MRI scans do not require radiation to obtain the images.The scanner is a big, donut shaped machine that uses magnets and the water we all have in our bodies to create pictures. It is harder to scan the lungs as they also contain lots of air, which appears black in an MRI image. This means good picture quality used to be difficult to achieve. However, there are lots of new techniques being developed so that lung MRI can now provide very detailed pictures.Who are our students & what are they working on?Yves
Developing and disseminating lung MRI methods – University of SheffieldIn MAGNIFY, we are particularly interested in the information we can get from gas MRI. This is where patients breathe in a harmless gas called xenon which is specially magnetised, or ‘hyperpolarised’. This then shows up brightly on the scans and helps us understand how well the lungs are working. However, gas MRI requires resources not available to all CF centres and can be difficult to undertake on young children. Yves will further develop scans that use hyperpolarised gas, as well as scans that don’t need gas, and develop a software package to process them. Her work will help more healthcare professionals better use and understand MRI.Yves started her PhD in October 2024.Demi
Developing lung MRI as an assessment tool in research – University of SheffieldNew treatments are tested in research trials using different outcome measures. For example, researchers might look at whether someone’s lung function improves after treatment. However, trials often require lots of people to take part, meaning they take a long time and cost a lot of money. MRI could be a good alternative measures as the detail it provides may mean less people need to take part in trials to find out. Demi is scanning lots of people with CF to investigate how we might be able to use MRI in this way.Demi started her PhD in March 2025.Dan
Developing a toolkit to support communication of lung MRI results – University of NottinghamAlthough lung MRI provides detailed images, it’s also important people can understand the results. Dan is developing an online toolkit with different resources about lung MRI. This will help healthcare professionals and people with CF (pwCF) and their families talk about the results. It will also help them understand what MRI can show and how it is different from their usual tests. To do this, Dan is talking to pwCF, carers and healthcare professionals to better understand their thoughts on lung imaging.Dan started his PhD in October 2023.Jonathan
Using MRI to develop a computer model to show how inhaled drugs move through the lungs in CF - University of ManchesterInhaled drugs are important in CF, but we don't know a lot about how drug particles move through the airways and where they land (deposit) inside the lungs.When some parts of the lungs are damaged in CF, this can change how air moves through other parts of the lung as well, and affect how drugs deposit.Jonathan is developing computer models that use gas MRI to look at how CF affects this process. These can be used to test how well new inhaled drugs reach different areas of the lung.Jonathan started his PhD in January 2024.

Jonathan presenting at UKCFC 2025
UK CF Conference 2025We were thrilled to have the opportunity to present about our research at the recent UK CF Conference (UKCFC) in London, organised by the CF Trust. There were lots of presentations and posters covering all the different types of research taking place in CF. We each had the opportunity to give a 90 second 'flash talk' and display a poster about our work. These are our highlights from the event:Yves:Demi:Dan: "I really enjoyed speaking to people about my research at the conference. It meant a lot for people to come up to me and show an interest in what I was doing. It made me realise that I've made quite a bit of progress in the last two years!"Jonathan:You can view our posters from the conference here [LINK TO BE ADDED].Thanks for reading our first blog – we look forward to sharing more about MAGNIFY in the next edition!